Nature 619 , 475486 (2023)
Retatrutide is the first medication to mimic three hormones, GLP-1, GIP and glucagon, rather than the one or two that current medications use
FDA & NAFDAC Approved Clinically tested and proven for safety and efficacy
Sophia Hua, a health policy researcher at the University of Pennsylvania, has argued that U.S
The modest level of weight loss, approximately 5 %, may fall below thresholds typically associated with measurable bone loss, which could partly explain the neutral findings
Aging cardiomyocytes, under the combined effects of pump failure, neuroendocrine overactivation, metabolic remodeling, and oxidative stress, further exacerbate gut microbiota -diversity loss and metabolite imbalance via mechanisms such as aggravated insulin resistance, advanced glycation end-product accumulation, and metabolic acidosis